MCID: PRC010
MIFTS: 30

Pericardial Mesothelioma malady

Categories: Cancer diseases, Cardiovascular diseases

Aliases & Classifications for Pericardial Mesothelioma

About this section

Aliases & Descriptions for Pericardial Mesothelioma:

Name: Pericardial Mesothelioma 10 12 65
Malignant Mesothelioma of Pericardium 10
 
Malignant Pericardial Mesothelioma 10

Classifications:



External Ids:

Disease Ontology10 DOID:6201
ICD1027 C45.2
UMLS65 C0346110, C0854883, C1335381

Summaries for Pericardial Mesothelioma

About this section
MalaCards based summary: Pericardial Mesothelioma, also known as malignant mesothelioma of pericardium, is related to partial of retinal vein occlusion and thyroid sarcoma. An important gene associated with Pericardial Mesothelioma is ERF (ETS2 Repressor Factor). Affiliated tissues include lung, bone and thyroid, and related mouse phenotype cellular.

Related Diseases for Pericardial Mesothelioma

About this section

Diseases related to Pericardial Mesothelioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 191)
idRelated DiseaseScoreTop Affiliating Genes
1partial of retinal vein occlusion10.4PTGER4, THBD
2thyroid sarcoma10.4FOXK1, HBA1
3skin angiosarcoma10.4FOXK1, HBA1
4selective iga deficiency disease10.4ERF, HBA1
5endometrioid ovary carcinoma10.4FOXK1, SMUG1
6enamel erosion10.4HBA1, THBD
7bone peripheral neuroepithelioma10.4HBA1, MB
8sclerosing liposarcoma10.4HBA1, MB
9fallopian tube papillary adenocarcinoma10.3CALB2, PTGER4
10anal buschke-lowenstein tumor10.3KRT7, PTGER4
11pilar sheath acanthoma10.3KRT7, PTGER4
12neurotic disorder10.3PTGER4, SMUG1
13visual verbal agnosia10.3MB, SMUG1
14cervical wilms' tumor10.3MPO, SMUG1
15dermis tumor10.3HBA1, MB
16brachial plexus neuritis10.3MB, SMUG1
17bronchiolo-alveolar adenocarcinoma10.3KRT7, PTGER4
18spindle cell variant squamous cell breast carcinoma10.3CALB2, THBD
19superior vena cava leiomyosarcoma10.3HBA1, SMUG1
20cryptogenic organizing pneumonia10.3MPO, SMUG1
21vaginal villous adenoma10.3HBA1, SMUG1
22angioid streaks of choroid10.3MB, SMUG1
23serous surface papilloma10.3KRT7, THBD
24parachordoma10.3CALB2, THBD
25multifocal osteogenic sarcoma10.3HBA1, KRT7
26freemartinism10.3CALB2, HBA1
27staphyloenterotoxemia10.2CALB2, MB
28substance abuse10.2HBA1, MB
29congenital structural myopathy10.2KRT7, THBD
30balkan nephropathy10.2MPO, THBD
31bronchus cancer10.2CALB2, HBA1
32breast pericanalicular fibroadenoma10.2KRT7, THBD
33hemosiderosis10.2KRT7, MPO
34prostate malignant phyllodes tumor10.2KRT7, SMUG1
35leukemia10.2
36retinitis10.2
37cerebellar disease10.2CALB2, THBD
38allergic contact dermatitis10.2KRT7, SMUG1
39endometrial small cell carcinoma10.2KRT7, THBD
40placenta accreta10.2HBA1, MB
41tricuspid valve stenosis10.2CALB2, KRT7
42fibrous synovial sarcoma10.2CALB2, KRT7
43ovarian cystadenoma10.2CALB2, KRT7
44pulmonary vein leiomyosarcoma10.2CALB2, PTGER4, THBD
45arteriosclerosis obliterans10.2CALB2, SMUG1
46seminal vesicle adenocarcinoma10.2CALB2, PTGER4, THBD
47diffuse pulmonary fibrosis10.2CALB2, PTGER4, THBD
48extrahepatic bile duct adenoma10.1KRT19, KRT7
49squamous papillomatosis10.1KRT19, KRT7
50penis paget's disease10.1KRT19, KRT7

Graphical network of the top 20 diseases related to Pericardial Mesothelioma:



Diseases related to pericardial mesothelioma

Symptoms for Pericardial Mesothelioma

About this section

Drugs & Therapeutics for Pericardial Mesothelioma

About this section

Drugs for Pericardial Mesothelioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 18)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
CisplatinapprovedPhase 2254015663-27-184093, 441203, 2767
Synonyms:
(SP-4-1)-diamminedichloridoplatinum
(SP-4-1)-diamminedichloroplatinum
(SP-4-2)-diamminedichloridoplatinum
(SP-4-2)-diamminedichloroplatinum
Abiplatin
Biocisplatinum
Briplatin
CACP
CDDP
CHEBI:35852
CID441203
CPD0-1392
CPDC
CPDD
Carboquone
Cis Pt II
Cis-DDP
Cis-Diaminedichloroplatinum
Cis-Diamminedichloroplatinum
Cismaplat
Cisplatin
Cisplatine
Cisplatino
Cisplatinum
Cisplatyl
Citoplationo
DB00515
DDP
DDPT
Diamminedichloroplatinum
 
EU-0100918
Lederplatin
Neoplatin
Peyrone's chloride
Peyrone's salt
Plastin
Platamine
Platiblastin
Platidiam
Platinex
Platinol
Platinol-AQ
Platinol-aq
Platinoxan
Platinum Ammine Chloride
Platinum Ammonium Chloride
Platinum Diamine Dichloride
Randa
Trans-DDP
Trans-Diaminedichloroplatinum
Trans-Diamminedichloroplatinum
Trans-Dichlorodiammine Platinum
Trans-Platinumdiammine Dichloride
cis-DDP
cis-Diamminedichloroplatinum
cis-Dichlorodiammineplatinum(II)
cis-[PtCl2(NH3)2]
cis-diamminedichloridoplatinum(II)
cis-diamminedichloroplatinum(II)
nchembio773-comp1
trans-diamminedichloridoplatinum(II)
2
Pemetrexedapproved, investigationalPhase 2580150399-23-8446556, 60843
Synonyms:
(2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid
(2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid
137281-23-3
150399-23-8
1juj
2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid
2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID
AC1L1U1D
AC1L2PDW
AC1L98DY
AC1L9JT6
AC1OCF51
AC1Q5R1W
Alimta
Alimta (TN)
Bio-0078
C20H19N5O6.2Na
C20H21N5O6
CHEBI:195145
CHEBI:43746
CHEBI:474008
CHEMBL1200373
CHEMBL225072
CHEMBL59843
CID125891
CID394493
CID446556
CID60843
CID6918197
D03828
D07472
DB00642
Disodium N-(p-(2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)-L-glutamate
HSDB 7316
 
I06-1253
I06-1294
I06-2128
L-Glutamic acid, N-(4-(2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)-, disodium salt
LS-172988
LS-173384
LY 231,514
LY 231514
LY-231,514
LY-2315
LY-231514
LY231514
LY231514 disodium
LYA
N-(4-(2-(2-Amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid
NCGC00167517-01
NCI60_035021
NSC698037
Pemetrexed
Pemetrexed (INN)
Pemetrexed Disodium
Pemetrexed [INN:BAN]
Pemetrexed disodium
Pemetrexed disodium (USAN)
Pemetrexed disodium [USAN]
Rolazar
SID50112739
ST51053024
Tifolar
UNII-04Q9AIZ7NO
UNII-2PKU919BA9
disodium (2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate
disodium (2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate
n-{4-[2-(2-amino-4-oxo-4,7-dihydro-1h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-d-glutamic acid
nchembio.108-comp6
3
Folic Acidapproved, nutraceuticalPhase 2292459-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic Acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
 
Folsaeure
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
4Nucleic Acid Synthesis InhibitorsPhase 23836
5Vitamin B ComplexPhase 22847
6Folic Acid AntagonistsPhase 21643
7Vitamin B9NutraceuticalPhase 22924
8Folinic AcidNutraceuticalPhase 22604
9FolateNutraceuticalPhase 22924
10
Histamine Phosphateapproved90651-74-165513
Synonyms:
1H-Imidazole-4-ethanamine, phosphate (1:2)
2-Imidazol-4-ylethylamine orthophosphoric acid (1:2)
4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)
4-(2-Aminoethyl)imidazole di-acid phosphate
4-2(2-Aminoethyl)Imidazole-Di-Acid Phosphate
51-74-1
53623-99-7
74-56-6
AC1L23E4
CID65513
D04445
DB00667
EINECS 200-118-4
 
H0147
Histamine Positive Skin Test Control
Histamine Positive skin test control
Histamine acid phosphate
Histamine biphosphate
Histamine dihydrogen phosphate
Histamine diphosphate
Histamine phosphate (1:2)
Histamine phosphate (TN)
Histamine phosphate (USP)
Histamine phosphate [USP]
Histamine positive
Histaminum
LS-78569
UNII-QWB37T4WZZ
11
Doxepinapproved131668-19-5667477, 667468
Synonyms:
(3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine
(3E)-3-dibenzo[b,e]oxepin-11(6H)-ylidene-N,N-dimethylpropan-1-amine
(3Z)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-di(methyl)propan-1-amine
(3Z)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine
(3Z)-3-dibenzo[b,e]oxepin-11(6H)-ylidene-N,N-dimethylpropan-1-amine
(Z)-Doxepin
11-(3-(Dimethylamino)propylidene)-6H-dibenz(b,e)oxepine
11-(3-Dimethylamino-propyliden)-6,11-dihydro-dibenz(b,e)oxipin
11-(3-Dimethylaminopropylidene)-6,11-dihydrodibenz(b,e)oxipin
1668-19-5
3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine
3-Dibenz[b,e]oxepin-11(6H)-ylidene-N,N-dimethyl-1-propanamine
3-dibenzo[b,e]oxepin-11(6H)-ylidene-N,N-dimethylpropan-1-amine
3607-18-9
AC1L1FAW
AC1LDI5F
AC1LDI63
AC1NUW4A
AKOS001582771
Adapin
Aponal
BPBio1_000118
BRD-K36616567-003-01-5
BRD-K37694030-003-02-8
BRD-K54462405-003-03-3
BSPBio_000106
BSPBio_001934
C06971
C19H21NO
CAS-1229-29-4
CCRIS 9176
CHEBI:36691
CHEBI:36692
CHEBI:4710
CHEMBL101740
CID10039438
CID3158
CID5462131
CID667468
CID667477
Cidoxepin
Cidoxepin [INN]
Cidoxepina
Cidoxepinum
Curatin
D07875
DB01142
DivK1c_000431
Doxepin
Doxepin (INN)
Doxepin (Z)-isomer
Doxepin Hcl
Doxepin Hydrochloride
Doxepin Hydrochloride,
Doxepin [USAN]
 
Doxepin, Hydrochloride
Doxepina
Doxepina [INN-Spanish]
Doxepine
Doxepinum
Doxepinum [INN-Latin]
HSDB 3069
IDI1_000431
KBio1_000431
KBio2_001285
KBio2_003853
KBio2_006421
KBio3_001154
KBioGR_001131
KBioSS_001285
L000699
LS-174582
LS-61638
Lopac-D-4526
Lopac0_000339
MF 10
MOLI001594
MolPort-003-847-024
MolPort-005-933-834
N,N-Dimethyldibenz(b,e)oxepin-delta(11(6H),gamma)-propylamine
NCGC00015344-01
NCGC00015344-02
NCGC00015344-04
NCGC00024623-01
NCGC00024623-02
NCGC00162127-01
NINDS_000431
Oprea1_473232
Prestwick0_000263
Prestwick1_000263
Prestwick2_000263
Prestwick3_000263
Prudoxin
Quitaxon
SPBio_000206
SPBio_002325
Silenor
Sinequan
Sinequan (TN)
Spectrum2_000133
Spectrum3_000407
Spectrum4_000526
Spectrum5_001051
Spectrum_000805
Tocris-0508
Triadapin
UNII-5ASJ6HUZ7D
UNII-F96TTB8728
Zonalon
cis-N-(3-(6H-Dibenz(b,e)oxepin-11-yliden)propyl)-N,N-dimethylamin
cis-doxepin
doxepin
12Neurotransmitter Agents14795
13Pharmaceutical Solutions7004
14Psychotropic Drugs5501
15
histamine90675614-87-8, 51-45-6774
Synonyms:
.beta.-Imidazolyl-4-ethylamine
1H-Imidazole-4-ethanamine
1H-Imidazole-5-ethanamine
1avn
1qft
2-(1H-Imidazol-4-yl)ethanamine
2-(1H-Imidazol-4-yl)ethylamine
2-(1H-Imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethylamine
2-(1H-imidazol-4-yl)ethan-1-amine
2-(1H-imidazol-5-yl)ethanamine
2-(3H-Imidazol-4-yl)-ethylamine
2-(4-Imidazolyl)ethanamine
2-(4-Imidazolyl)ethylamine
2-Imidazol-4-yl-Ethylamine
2-Imidazol-4-ylethylamine
2-[4-Imidazolyl]ethylamine
4-(2-Aminoethyl)-1H-imidazole
4-(2-Aminoethyl)imidazole
4-Imidazoleethylamine
5-Imidazoleethylamine
51-45-6
53290_FLUKA
64422-25-9
924364-91-0
AC-13185
AC1L19ZT
AC1Q54BV
AC1Q54BW
AKOS000274386
ALBB-005968
BCBcMAP01_000250
BSPBio_001117
BSPBio_002124
Bio1_000487
Bio1_000976
Bio1_001465
Bio2_000389
Bio2_000869
C00388
CCRIS 6535
CHEBI:18295
CHEMBL90
CID774
D08040
DivK1c_000308
EINECS 200-100-6
Eramin
Ergamine
Ergotidine
F411C768-A159-4FC0-A195-291A08BB03AA
Free histamine
H7125_SIGMA
HMS1362G19
HMS1792G19
HMS1990G19
HSDB 3338
HSM
Histamine
Histamine (DCF)
Histamine Base
Histamine [USAN]
Histamine, Free Base
Histaminum
 
Histaminum (TN)
IDI1_000308
IDI1_002144
Imidazole-4-ethylamine
Istamina
Istamina [Italian]
KBio1_000308
KBio2_000457
KBio2_001325
KBio2_003025
KBio2_003893
KBio2_005593
KBio2_006461
KBio3_000853
KBio3_000854
KBio3_001344
KBioGR_000457
KBioGR_001580
KBioSS_000457
KBioSS_001325
L-Histamin base
L-Histamine
L-histamine
L000292
LS-75835
Lopac-H-7250
Lopac0_000595
MLS000069447
MolPort-001-785-597
MolPort-002-042-264
NCGC00015513-01
NCGC00015513-08
NCGC00093371-02
NCGC00093371-03
NCGC00093371-04
NCGC00093371-05
NINDS_000308
NSC 33792
NSC33792
SDCCGMLS-0066601.P001
SMP1_000151
SMR000059091
SPBio_000729
ST073926
STK346752
STOCK5S-55669
Spectrum2_000665
Spectrum3_000452
Spectrum4_000960
Spectrum5_000796
Spectrum_000845
Theramine
UNII-820484N8I3
WLN: T5M CNJ D2Z
ZERO/004089
[3H]histamine
b-Imidazolyl-4-ethylamine
beta-Aminoethylglyoxaline
beta-Aminoethylimidazole
beta-Aminothethylglyoxaline
beta-Imidazolyl-4-ethylamine
beta-aminothethylglyoxaline
bmse000744
histamine
nchembio.87-comp54
nchembio714-comp1
16Antidepressive Agents2367
17Antidepressive Agents, Tricyclic250
18Histamine Antagonists826

Interventional clinical trials:

idNameStatusNCT IDPhase
1Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC)CompletedNCT00942825Phase 2
2Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without ChemotherapyActive, not recruitingNCT02062632

Search NIH Clinical Center for Pericardial Mesothelioma

Genetic Tests for Pericardial Mesothelioma

About this section

Anatomical Context for Pericardial Mesothelioma

About this section

MalaCards organs/tissues related to Pericardial Mesothelioma:

33
Lung, Bone, Thyroid, Ovary, Endothelial, B cells, Myeloid

Animal Models for Pericardial Mesothelioma or affiliated genes

About this section

MGI Mouse Phenotypes related to Pericardial Mesothelioma:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053847.4ERF, FOXK1, KRT19, KRT7, MB, PTGER4

Publications for Pericardial Mesothelioma

About this section

Articles related to Pericardial Mesothelioma:

(show top 50)    (show all 101)
idTitleAuthorsYear
1
Elevated ZNF703 Protein Expression Is an Independent Unfavorable Prognostic Factor for Survival of the Patients with Head and Neck Squamous Cell Carcinoma. (26063961)
2015
2
Association between KRAS mutation and lung metastasis in advanced colorectal cancer. (25535726)
2015
3
Histone Methyltransferase SET1 Mediates Angiotensin II-Induced Endothelin-1 Transcription and Cardiac Hypertrophy in Mice. (25814673)
2015
4
IDH1 and IDH2 mutations confer an adverse effect in patients with acute myeloid leukemia lacking the NPM1 mutation. (24443894)
2014
5
Molecular, genetic and stem cell-mediated therapeutic strategies for spinal muscular atrophy (SMA). (24400925)
2014
6
Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma. (24500761)
2014
7
Clinical and histological features of leprosy and human immunodeficiency virus co-infection in Brazil. (23678890)
2013
8
Polymorphisms within the FANCA gene associate with premature ovarian failure in Korean women. (24045675)
2013
9
NF-I_B addiction and resistance to 5-fluorouracil in a multi-stage colon carcinoma model. (23259994)
2013
10
Left atrial myxoma in a patient with paroxysmal atrial fibrillation. (24154890)
2013
11
Adherence to a web-based physical activity intervention for patients with knee and/or hip osteoarthritis: a mixed method study. (24132044)
2013
12
Association between genetic variants of the ADD1 and GNB3 genes and blood pressure response to the cold pressor test in a Chinese Han population: the GenSalt Study. (22476228)
2012
13
Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma. (22952578)
2012
14
HFE gene polymorphism in the population of Northern Asia]. (22145371)
2011
15
Linear porokeratosis with nail dystrophy. (21697042)
2011
16
Preclinical studies of apogossypolone, a novel pan inhibitor of bcl-2 and mcl-1, synergistically potentiates cytotoxic effect of gemcitabine in pancreatic cancer cells. (19823097)
2010
17
Spontaneous extracutaneous systemic mastocytosis in a cynomolgus macaque (Macaca fascicularis). (19545986)
2010
18
Polymorphisms of drug-metabolizing enzymes genes in a Han Chinese population]. (20137266)
2009
19
Transcriptional regulation of the human gene coding for proline-rich nuclear receptor coactivator (pnrc) by regulatory factor x (rfx1)]. (19334528)
2009
20
Monitoring caspase-3 activation with a multimodality imaging sensor in living subjects. (18794090)
2008
21
Persistent airway inflammation and bronchial hyperresponsiveness in patients with totally controlled asthma. (17537187)
2008
22
Effect of metformin on IGF-1 and IGFBP-1 levels in obese patients with polycystic ovary syndrome. (17350746)
2008
23
New potential treatments for protection of pancreatic B-cell function in Type 1 diabetes. (19046214)
2008
24
Long-term L-carnitine administration reduces erythropoietin resistance in chronic hemodialysis patients with thalassemia minor. (21901057)
2007
25
The KISS1 metastasis suppressor: mechanistic insights and clinical utility. (16146758)
2006
26
Chemical chaperones and permissive temperatures alter localization of Gaucher disease associated glucocerebrosidase variants. (17163678)
2006
27
Mycophenolate mofetil use in hepatitis B associated-membranous and membranoproliferative glomerulonephritis induces viral replication. (15671086)
2005
28
Increased risk of obesity resulting from the interaction between high energy intake and the Trp64Arg polymorphism of the beta3-adrenergic receptor gene in healthy Japanese men. (16276029)
2005
29
First branchial cleft anomaly, a case for misdiagnosis. (15506316)
2004
30
Etoposide upregulates Bax-enhancing tumour necrosis factor-related apoptosis inducing ligand-mediated apoptosis in the human hepatocellular carcinoma cell line QGY-7703. (12823542)
2003
31
Covert bacteriuria in nephrotic syndrome. (12593564)
2002
32
Bone mineral density, biochemical markers of bone turnover, and hormonal status in men with systemic lupus erythematosus. (11765229)
2001
33
Neuromodulation in polycystic ovary syndrome. (11293003)
2001
34
Scabies. (11954437)
2001
35
Aberrant expression of cytokeratin 7 as a histological marker of progression in primary biliary cirrhosis. (11169073)
2001
36
Familial hypocalciuric hypercalcemia and other disorders with resistance to extracellular calcium. (11033758)
2000
37
Ex vivo interferon-gamma response to human immunodefiency virus-1 derived peptides in human immunodeficiency virus-1 infected patients. (10736117)
2000
38
Lichenoid and subacute cutaneous lupus erythematosus-like dermatitis associated with antihistamine therapy. (10082400)
1999
39
Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. (9216960)
1997
40
Comparison of reactivity of monoclonal antibody (3F2) to trimeric tumor necrosis factor (TNF-alpha) with that to monomeric TNF-alpha. (8537321)
1995
41
Anti-neutrophil cytoplasmic antibody for proteinase 3 in a child with polyarteritis nodosa. (7754755)
1995
42
The effect of recombinant human erythropoietin treatment on the endurance performance of Sprague-Dawley rats. (8171272)
1994
43
Involvement of pp60c-src with two major signaling pathways in human breast cancer. (7506422)
1994
44
Disseminated intravascular coagulation in adult-onset Still's disease with neurological, respiratory and hepatic sequelae. (8220844)
1993
45
Two new polymorphisms but no mutations of the KIT gene in patients with myelodysplasia at positions corresponding to human FMS and murine W locus mutational hot spots. (7694008)
1993
46
Elevated expression of beta 1 and beta 2 integrins, intercellular adhesion molecule 1, and endothelial leukocyte adhesion molecule 1 in the skin of patients with systemic sclerosis of recent onset. (1371389)
1992
47
Disseminated neonatal herpes simplex virus infection with necrotizing encephalitis--an autopsy case. (3271053)
1987
48
Macrosaccadic oscillation, saccadic dysmetria and motor error in spinocerebellar degeneration. (3831488)
1985
49
Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine. (7263835)
1981
50
Coronary and aortic atherosclerosis in New Orleans. I. Sampling bias due to source of autopsy specimens. (703258)
1978

Variations for Pericardial Mesothelioma

About this section

Expression for genes affiliated with Pericardial Mesothelioma

About this section
Search GEO for disease gene expression data for Pericardial Mesothelioma.

Pathways for genes affiliated with Pericardial Mesothelioma

About this section

GO Terms for genes affiliated with Pericardial Mesothelioma

About this section

Molecular functions related to Pericardial Mesothelioma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1oxygen transporter activityGO:00053449.7HBA1, MB

Sources for Pericardial Mesothelioma

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet